2-YEAR SURVIVAL - PREOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CERVICAL-CANCER STAGE-IB AND STAGE-II WITH BULKY TUMOR

被引：90
作者：
KIM, DS
MOON, H
KIM, KT
HWANG, YY
CHO, SH
KIM, SR
机构：
来源：
GYNECOLOGIC ONCOLOGY | 1989年 / 33卷 / 02期
关键词：
D O I：
10.1016/0090-8258(89)90557-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：225 / 230
页数：6
相关论文
共 37 条
  • [1] 10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER
    BONADONNA, G
    VALAGUSSA, P
    ROSSI, A
    TANCINI, G
    BRAMBILLA, C
    ZAMBETTI, M
    VERONESI, U
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) : 95 - 115
  • [2] BURGHARDT E, 1978, OBSTET GYNECOL, V52, P138
  • [3] ANALYSIS OF FACTORS CONTRIBUTING TO TREATMENT FAILURES IN STAGE-IB AND STAGE-II-A CARCINOMA OF THE CERVIX
    CHUNG, CK
    NAHHAS, WA
    STRYKER, JA
    CURRY, SL
    ABT, AB
    MORTEL, R
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 138 (05) : 550 - 556
  • [4] V-FACTOR (TUMOR VOLUME) AND T-FACTOR (FIGO CLASSIFICATION) IN THE ASSESSMENT OF CERVIX CANCER PROGNOSIS - THE RISK OF LYMPH-NODE SPREAD
    DARGENT, D
    FROBERT, JL
    BEAU, G
    [J]. GYNECOLOGIC ONCOLOGY, 1985, 22 (01) : 15 - 22
  • [5] ELLIAS EG, 1979, CANCER, V43, P1025
  • [6] CERVICAL-CARCINOMA - A DRUG-RESPONSIVE TUMOR - EXPERIENCE WITH COMBINED CISPLATIN, VINBLASTINE, AND BLEOMYCIN THERAPY
    FRIEDLANDER, M
    KAYE, SB
    SULLIVAN, A
    ATKINSON, K
    ELLIOTT, P
    COPPLESON, M
    HOUGHTON, R
    SOLOMON, J
    GREEN, D
    RUSSELL, P
    HUDSON, CN
    LANGLANDS, AO
    TATTERSALL, MHN
    [J]. GYNECOLOGIC ONCOLOGY, 1983, 16 (02) : 275 - 281
  • [7] HEYN RM, 1974, CANCER-AM CANCER SOC, V34, P2128, DOI 10.1002/1097-0142(197412)34:6<2128::AID-CNCR2820340638>3.0.CO
  • [8] 2-M
  • [9] HOGAN WM, 1982, CANCER-AM CANCER SOC, V49, P1278, DOI 10.1002/1097-0142(19820315)49:6<1278::AID-CNCR2820490634>3.0.CO
  • [10] 2-R
1234